Edition:
United Kingdom

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

15.50USD
4:18pm GMT
Change (% chg)

$0.30 (+1.97%)
Prev Close
$15.20
Open
$15.20
Day's High
$15.95
Day's Low
$15.20
Volume
29,131
Avg. Vol
33,820
52-wk High
$37.00
52-wk Low
$10.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.72 -0.986
Jun '17 0.86 -1.168
Mar '17 4.87 -2.184
FY 2016 Dec '16 7.95 -3.000
Sep '16 3.97 -3.103
Jun '16 3.42 -2.536
Mar '16 2.68 -3.073
FY 2015 Dec '15 5.79 -1.425
Sep '15 2.50 -3.139
Jun '15 5.05 -2.858
Mar '15 13.96 -2.041
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 2.83 4.57 1.10 8.87
Quarter Ending Mar-18 2 6.45 11.89 1.00 6.30
Year Ending Dec-17 3 9.84 12.02 8.50 21.04
Year Ending Dec-18 3 70.63 93.69 55.20 60.99
Earnings (per share)
Quarter Ending Dec-17 3 -0.72 -0.55 -0.96 -3.09
Quarter Ending Mar-18 2 -3.91 -1.01 -6.82 -1.60
Year Ending Dec-17 2 -4.99 -4.39 -5.60 -12.78
Year Ending Dec-18 4 -4.97 -3.14 -7.54 -10.60
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.76 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta 1.07 0.85 0.88
Price to Sales (TTM) 9.45 100.68 5.40
Price to Book (MRQ) 1.09 13.50 5.38
Price to Tangible Book (MRQ) 1.09 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 61.70 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -74.85 433.86 9.00
Sales (TTM) vs TTM 1 Yr. Ago 22.65 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.94 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 7.06 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -7.64 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 12.04 5.36 2.98
LT Debt to Equity (MRQ) 3.51 18.92 11.56
Total Debt to Equity (MRQ) 7.92 20.59 15.81
Interest Coverage (TTM) -71.46 -112.21 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -538.61 -- --
EBITD - 5 Yr. Avg -484.39 -261.12 15.24
Operating Margin (TTM) -558.94 -556.66 7.76
Operating Margin - 5 Yr. Avg. -484.80 -279.30 10.75
Pre-Tax Margin (TTM) -560.40 -529.90 8.57
Pre-Tax Margin - 5 Yr. Avg. -497.39 -279.03 11.17
Net Profit Margin (TTM) -560.40 -531.35 4.88
Net Profit Margin - 5 Yr. Avg. -497.39 -282.21 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 392,200 25,315,636 864,680,397
Net Income/Employee (TTM) -2,197,889 3,332,197 101,718,341
Receivable Turnover (TTM) 5.48 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.08 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.26 -0.77 11.00
Return on Assets - 5 Yr. Avg. -60.19 -0.26 12.43
Return on Investment (TTM) -48.67 2.36 14.46
Return on Investment - 5 Yr. Avg. -68.63 2.98 16.28
Return on Equity (TTM) -54.82 2.96 16.05
Return on Equity - 5 Yr. Avg. -97.29 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -34.03 32.11 --
EPS (TTM) % -12.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Melinta Therapeutics, Inc.

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.79 -2.68 50 53
13 Week -29.44 -32.88 13 60
26 Week -17.53 -23.80 35 69
52 Week -85.69 -87.87 2 46
YTD 13.39 -0.42 56 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 177
Total Shares Held: 12,888,139
3 Mo. Net Change: 6,417,553
# New Positions: 21
# Closed Positions: 13
# Increased Positions: 60
# Reduced Positions: 46
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.